Prime Medicine (PRME) Retained Earnings (2021 - 2025)
Historic Retained Earnings for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to -$842.3 million.
- Prime Medicine's Retained Earnings fell 3060.21% to -$842.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$842.3 million, marking a year-over-year decrease of 3060.21%. This contributed to the annual value of -$687.2 million for FY2024, which is 3986.77% down from last year.
- Prime Medicine's Retained Earnings amounted to -$842.3 million in Q3 2025, which was down 3060.21% from -$791.7 million recorded in Q2 2025.
- Over the past 5 years, Prime Medicine's Retained Earnings peaked at -$171.4 million during Q4 2021, and registered a low of -$842.3 million during Q3 2025.
- In the last 5 years, Prime Medicine's Retained Earnings had a median value of -$514.2 million in 2023 and averaged -$512.7 million.
- As far as peak fluctuations go, Prime Medicine's Retained Earnings crashed by 7108.4% in 2022, and later plummeted by 3060.21% in 2025.
- Quarter analysis of 5 years shows Prime Medicine's Retained Earnings stood at -$171.4 million in 2021, then plummeted by 71.08% to -$293.2 million in 2022, then crashed by 67.58% to -$491.3 million in 2023, then crashed by 39.87% to -$687.2 million in 2024, then dropped by 22.57% to -$842.3 million in 2025.
- Its Retained Earnings was -$842.3 million in Q3 2025, compared to -$791.7 million in Q2 2025 and -$739.1 million in Q1 2025.